The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change

The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change

Objective: The study compared the relative cost differences of similar orphan drugs among high and low GDP countries in Europe: Bulgaria, France, Germany, Greece, Hungary, Italy, Norway, Poland, Romania, Spain, Sweden, UK. Methods: Annual treatment costs per patient were calculated. Relative costs w...

Full description

Bibliographic Details
Main Authors: K. E. Young, I. Soussi, M. Toumi
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Journal of Market Access & Health Policy
Subjects:
Rare diseases
orphan drugs
pricing
differential pricing
external reference pricing
treatment cost
relative costs
affordability
ability to pay
Europe
Online Access:http://dx.doi.org/10.1080/20016689.2017.1369817

Internet

http://dx.doi.org/10.1080/20016689.2017.1369817

Similar Items